Clinical Pharmacology Considerations for Novel Therapeutic Modalities
1:00:00
Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies
1:57:16
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance
4:07:45
FDA Clinical Investigator Training Course (CITC) 2024 (Day 3 of 3)
2:47:58
FDA FY2025 Small Business Fair
4:38:30
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
4:59:26
FDA Clinical Investigator Training Course (CITC) 2024 (Day 2 of 3)
59:45
Clinicians Connect: Conversations w/ FDA's CMO on reducing cases of congenital syphilis & syphilis
50:02